Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Johan Broekman

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
The New England Journal of Medicine|September 27, 2002
COX inhibitors and thromboregulationAaron J Marcus, M Johan Broekman, David J Pinsky
The Journal of Pharmacology and Experimental Therapeutics|June 15, 2007
Targeted deletion of ectonucleoside triphosphate diphosphohydrolase 1/CD39 leads to desensitization of pre- and postsynaptic purinergic P2 receptorsUlrich Schaefer, Takuji Machida, M Johan Broekman, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 5, 2003
Ectonucleotidase in sympathetic nerve endings modulates ATP and norepinephrine exocytosis in myocardial ischemiaCasilde Sesti, Motohiro Koyama, M Johan Broekman, et al.
Trends in Cardiovascular Medicine|May 27, 2009
P2X(1) receptor inhibition and soluble CD39 administration as novel approaches to widen the cardiovascular therapeutic windowC Y E Fung, Aaron J Marcus, M Johan Broekman, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 24, 2002
EctoNucleotidase in cardiac sympathetic nerve endings modulates ATP-mediated feedback of norepinephrine releaseCasilde Sesti, M Johan Broekman, Joan H F Drosopoulos, et al.
The Journal of Biological Chemistry|December 1, 2010
Feedback regulation of endothelial cell surface plasmin generation by PKC-dependent phosphorylation of annexin A2Kai-Li He, Guangzhi Sui, Huabao Xiong, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 22, 2003
Metabolic control of excessive extracellular nucleotide accumulation by CD39/ecto-nucleotidase-1: implications for ischemic vascular diseasesAaron J Marcus, M Johan Broekman, Joan H F Drosopoulos, et al.
Blood|May 16, 2002
Platelet-erythrocyte interactions enhance alpha(IIb)beta(3) integrin receptor activation and P-selectin expression during platelet recruitment: down-regulation by aspirin ex vivoJuana Vallés, M Teresa Santos, Justo Aznar, et al.
Seminars in Thrombosis and Hemostasis|April 27, 2005
Role of CD39 (NTPDase-1) in thromboregulation, cerebroprotection, and cardioprotectionAaron J Marcus, M Johan Broekman, Joan H F Drosopoulos, et al.
Thrombosis Research|June 9, 2007
CD39/NTPDase-1 activity and expression in normal leukocytesE Dianne Pulte, M Johan Broekman, Kim E Olson, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
The New England Journal of Medicine|September 27, 2002
COX inhibitors and thromboregulationAaron J Marcus, M Johan Broekman, David J Pinsky
The Journal of Pharmacology and Experimental Therapeutics|June 15, 2007
Targeted deletion of ectonucleoside triphosphate diphosphohydrolase 1/CD39 leads to desensitization of pre- and postsynaptic purinergic P2 receptorsUlrich Schaefer, Takuji Machida, M Johan Broekman, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 5, 2003
Ectonucleotidase in sympathetic nerve endings modulates ATP and norepinephrine exocytosis in myocardial ischemiaCasilde Sesti, Motohiro Koyama, M Johan Broekman, et al.
Trends in Cardiovascular Medicine|May 27, 2009
P2X(1) receptor inhibition and soluble CD39 administration as novel approaches to widen the cardiovascular therapeutic windowC Y E Fung, Aaron J Marcus, M Johan Broekman, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 24, 2002
EctoNucleotidase in cardiac sympathetic nerve endings modulates ATP-mediated feedback of norepinephrine releaseCasilde Sesti, M Johan Broekman, Joan H F Drosopoulos, et al.
The Journal of Biological Chemistry|December 1, 2010
Feedback regulation of endothelial cell surface plasmin generation by PKC-dependent phosphorylation of annexin A2Kai-Li He, Guangzhi Sui, Huabao Xiong, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 22, 2003
Metabolic control of excessive extracellular nucleotide accumulation by CD39/ecto-nucleotidase-1: implications for ischemic vascular diseasesAaron J Marcus, M Johan Broekman, Joan H F Drosopoulos, et al.
Blood|May 16, 2002
Platelet-erythrocyte interactions enhance alpha(IIb)beta(3) integrin receptor activation and P-selectin expression during platelet recruitment: down-regulation by aspirin ex vivoJuana Vallés, M Teresa Santos, Justo Aznar, et al.
Seminars in Thrombosis and Hemostasis|April 27, 2005
Role of CD39 (NTPDase-1) in thromboregulation, cerebroprotection, and cardioprotectionAaron J Marcus, M Johan Broekman, Joan H F Drosopoulos, et al.
Thrombosis Research|June 9, 2007
CD39/NTPDase-1 activity and expression in normal leukocytesE Dianne Pulte, M Johan Broekman, Kim E Olson, et al.
Pageof 3